Paper Review Records
All Paper Review Records
21 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
116
days
Primary Myelofibrosis ( PMF )—The German ONKOPEDIA Guideline 2025
Authors
Martin Griesshammer; Haifa Kathrin Al‐Ali; Gabriela M. Baerlocher; Konstanze Döhner; Steffen Koschmieder; Nicolaus Kröger; Petro E. Petrides; Dominik Wolf; Florian H. HeidelShow moreShow less
Affiliations
1. University Clinic for Hematology, Oncology, Haemostaseology and Palliative Care, Johannes Wesling Medical Center Minden, University of Bochum Minden Germany; 2. Krukenberg Cancer Center University Hospital of Halle Halle Germany; 3. Clinic for Hematology and Oncology, Hirslanden Zürich Zürich Switzerland; 4. Medica Medical Laboratories and Pathology Zürich Switzerland; 5. Department of Internal Medicine III, Section Myeloid Neoplasms University Hospital Ulm Ulm Germany; 6. Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine RWTH Aachen University Aachen Germany; 7. Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD) Aachen Germany; 8. Department for Hematology and Stem Cell Transplantation University of Essen Essen Germany; 9. Hematology Oncology Center Munich and Ludwig Maximilians University Munich Munich Germany; 10. Universitätsklinik für Innere Medizin V Innsbruck Austria; 11. Hematology, Hemostasis, Oncology, and Cell Therapy, Hannover Medical School Hannover GermanyShow moreShow less
116
days
The German ONKOPEDIA Guideline for Myelofibrosis in 2025—Recommendations of an MPN Expert Panel of the German Society for Hematology and Oncology ( DGHO )
Authors
Martin Griesshammer; Haifa Kathrin Al‐Ali; Gabriela M. Baerlocher; Konstanze Döhner; Steffen Koschmieder; Nicolaus Kröger; Petro E. Petrides; Dominik Wolf; Florian H. HeidelShow moreShow less
Affiliations
1. University Clinic for Hematology, Oncology, Haemostaseology and Palliative Care, Johannes Wesling Medical Center Minden University of Bochum Minden Germany; 2. Krukenberg Cancer Center University Hospital of Halle Halle Germany; 3. Clinic for Hematology and Oncology Hirslanden Zürich AG Zürich Switzerland; 4. Medica Medical Laboratories and Pathology Medizinische Laboratorien Dr. F. Kaeppeli AG Zürich Switzerland; 5. Department of Internal Medicine III University Hospital Ulm Ulm Germany; 6. Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine RWTH Aachen University Aachen Germany; 7. Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD) Aachen Germany; 8. University Clinic for Hematology and Stem Cell Transplantation Essen Germany; 9. Hematology Oncology Center Munich and Ludwig Maximilians University Munich Munich Germany; 10. Universitätsklinik für Innere Medizin V Innsbruck Austria; 11. Hematology, Hemostasis, Oncology, and Cell Therapy Hannover Medical School Hannover GermanyShow moreShow less
126
days
TRIM24 in Human Cancers: A Dual‐Function Oncoprotein, Regulatory Mechanisms, and Emerging Therapeutic Strategies
Authors
Wenjie Zeng; Keke Xu; Yuezhou Wang; Yiyi Shou; Hao Xiong; Lanqing Liang; Hong'en Xu; Ruiqi Liu; Haibo Zhang; Yanwei LuShow moreShow less
Affiliations
1. Cancer Center, Department of Radiation Oncology Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College Hangzhou Zhejiang China; 2. School of Laboratory Medicine and Bioengineering, Hangzhou Medical College Hangzhou Zhejiang China; 3. College of Stomatology, Wenzhou Medical University Wenzhou China; 4. Tongde Hospital of Zhejiang Province Affiliated to Zhejiang Chinese Medical University (Tongde Hospital of Zhejiang Province) Hangzhou Zhejiang China; 5. Zhejiang Academy of Traditional Chinese Medicine Hangzhou Zhejiang ChinaShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days